跳至主要内容
临床试验/NCT07843147
NCT07843147尚未招募不适用

Studies of Blood Glucose and the Microbiome in Tumors and Cysts of the Pancreas

Umeå University0 个研究点目标入组 100 人开始时间: 2026年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
主要终点
Difference in gut microbiota composition

研究概览

简要总结

This prospective, single-center observational study investigates whether continuous glucose monitoring (CGM, 14 days) and gut microbiota composition (from a fecal sample) reveal patterns specific to pancreatic cancer, aiming to contribute to earlier detection and better assessment of disease severity. Adult patients under investigation, follow-up, or treatment for benign or malignant pancreatic/periampullary conditions are invited to participate in either or both parts of the study.

详细描述

See Appendix 1 (Research Plan) for a full description of the background, aims, and methods.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adults (≥18 years of age).
  • •Undergoing clinical investigation, follow-up, or treatment for a pancreatic or periampullary condition (malignant or benign/premalignant, including cystic lesions and pancreatitis).
  • •Willing and able to provide written informed consent for participation in at least one component of the study (continuous glucose monitoring and/or fecal sample collection).

排除标准

  • 未提供

研究组 & 干预措施

Patients with pancreatic cancer

Patients with cysts or other benign pancreatic disease

结局指标

主要结局

Difference in gut microbiota composition

时间窗: Single fecal sample

Difference in CGM-derived glycemic variability metrics

时间窗: 14 days CGM recording period

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验